News Home

Is Johnson & Johnson (JNJ) a Laggard in the Healthcare Sector?

Thursday, November 30, 2023 03:25 PM | InvestorsObserver Analysts

Mentioned in this article

Is Johnson & Johnson (JNJ) a Laggard in the Healthcare Sector?

A rating of 13 puts Johnson & Johnson (JNJ) near the top of the Healthcare sector according to InvestorsObserver. Johnson & Johnson's score of 13 means that it ranks higher than 13% of stocks in the sector. In addition, its overall score of 5 ranks it higher than 5% of all stocks.

Overall Score - 5
JNJ has an Overall Score of 5. Find out what this means to you and get the rest of the rankings on JNJ!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 5 means the stock is more attractive than 5 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Johnson & Johnson Stock Today?

Johnson & Johnson (JNJ) stock has risen 1.53% while the S&P 500 is down -0.09% as of 3:18 PM on Thursday, Nov 30. JNJ has gained $2.33 from the previous closing price of $152.12 on volume of 4,041,629 shares. Over the past year the S&P 500 has gained 11.43% while JNJ is down -13.23%. JNJ earned $13.51 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 11.43. Click Here to get the full Stock Report for Johnson & Johnson stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App